A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke

General Information

Summary This is a single centre, single arm, open-label, to investigate the safety and efficacy of EPC transplantation in the brain.
Clinical trials phase Other
Start date (estimated) 2018-12-01
End date (estimated) 2020-12-31
Clinical feature
Label Ischemic Stroke
Link http://purl.obolibrary.org/obo/NCIT_C95802
Description An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.

Administrative Information

NCT number NCT03726814
ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=NCT03726814
Other study identifiers
Name EPC-BJYY-01
Source weblink https://clinicaltrials.gov/ct2/show/NCT03726814
Public contact
Email allife@allifetech.com
Public email allife@allifetech.com
City Beijing
Sponsors Allife Medical Science and Technology Co., Ltd.


Which differentiated cell type is used
Label Endothelial Progenitor Cell
Link http://purl.obolibrary.org/obo/NCIT_C124145
Description Circulating cells that express a variety of cell surface markers similar to those expressed by vascular endothelial cells, adhere to endothelium at sites of hypoxia or ischemia, and participate in new vessel formation.


Recruitment Status Not yet recruiting
Estimated number of participants 12